论文部分内容阅读
目的探讨醒脑静联合舒血宁治疗颅脑创伤后昏迷的安全性。方法选取120例颅脑创伤后昏迷病人,根据患者的受伤机制、年龄、格拉斯哥昏迷评分(GCS)半随机均等分为常规治疗组(n=60)和联合治疗组(n=60)。比较两组患者治疗前及治疗1、8、15、22、30 d后的GCS评分,观察治疗期间病人意识觉醒恢复时间、呼吸衰竭纠正时间、格拉斯哥预后评分(GOS)。两组患者康复治疗6-12个月后,记录常规治疗组和联合治疗组患者的治疗总有效率。结果两组患者治疗前、治疗后1 d GCS评分差异无统计学意义(P>0.05),治疗后8、15、22、30 d两组GCS评分差异均有统计学意义(P<0.05)。联合治疗组觉醒时间和呼吸衰竭纠正时间分别为(9.3±2.8)d、(6.9±2.6)d,低于常规治疗组的(11.6±2.9)d、(10.1±2.2)d(P<0.05);联合治疗组的1周清醒率高于常规治疗组(63.3%vs.33.3%),差异有统计学意义(P<0.05)。结论颅脑创伤后昏迷患者予以脑醒静联合舒血宁治疗效果显著,能够有效促进神经系统功能的恢复,提高临床治愈率。
Objective To investigate the safety of xingnaojing combined with shuxuening in treating coma after traumatic brain injury. Methods One hundred and twenty patients were randomly divided into routine treatment group (n = 60) and combination therapy group (n = 60) according to the patient’s injury mechanism, age and Glasgow Coma Scale (GCS). The GCS scores of the two groups were compared before treatment and after treatment for 1, 8, 15, 22 and 30 days. The recovery time of patients’ consciousness, the time of respiratory failure correction and Glasgow Outcome Scale (GOS) were observed. After 6-12 months of rehabilitation in both groups, the total effective rate of treatment was recorded in both the conventional and combined groups. Results There was no significant difference in GCS scores between the two groups before treatment and one day after treatment (P> 0.05). There were significant differences in GCS scores between the two groups at 8, 15, 22 and 30 days after treatment (P <0.05). The corrected time of awakening and respiratory failure were (9.3 ± 2.8) days and (6.9 ± 2.6) days in the combined treatment group, which were lower than those in the conventional treatment group (11.6 ± 2.9 and 10.1 ± 2.2) days (P <0.05) . The awakening rate of the combined therapy group was higher than that of the conventional therapy group (63.3% vs.33.3%), the difference was statistically significant (P <0.05). Conclusions Patients with coma after craniocerebral trauma were treated with Naoxingjing combined with Shuxuening, which could effectively promote the recovery of nervous system function and improve the clinical cure rate.